Skip to main content

Table 4 Antimicrobial susceptibility pattern of K. pneumoniae isolates

From: Klebsiella pneumoniae pneumonia in patients with rheumatic autoimmune diseases: clinical characteristics, antimicrobial resistance and factors associated with extended-spectrum β-lactamase production

Antibiotics

Susceptibility (N = 60)

Resistance

Imipenem

56 (93.3%)

6.7%

Meropenem

55 (91.7%)

8.3%

Ertapenem

55 (91.7%)

8.3%

Amikacin

54 (90.0%)

10.0%

Tigecycline

48 (80.0%)

20.0%

Cefperazone-sulbactam

44 (73.3%)

26.7%

Piperacillin-tazobactam

40 (66.7%)

33.3%

Gentamicin

39 (65.0%)

35.0%

Ceftazidime

38 (63.3%)

36.7%

Cefepime

37 (61.7%)

38.3%

Aztreonam

34 (56.7%)

43.3%

Amoxicillin-clavulanic acid

33 (55.0%)

45.0%

Ceftriaxone

31 (51.7%)

48.3%

Levofloxacin

30 (50.0%)

50.0%

Minocycline

30 (50.0%)

50.0%

Sulfamethoxazole trimethoprim

29 (48.3%)

51.7%

Cefuroxime

27 (45.0%)

55.0%

Ciprofloxacin

26 (43.3%)

56.7%

  1. Strains showing “intermediate” in antimicrobial susceptibility testing were included as “non-susceptible” isolates
  2. Resistance (%) = 1- susceptibility (%)